Advertisement
Screener

Diebold Nixdorf, Incorporated (DBD) Scorecard

2.8 / 5 stars · 68/120 Roast Me

Diebold Nixdorf, Incorporated (DBD) Scorecard

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
22/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseDBD / S&P
12.70% / 15.20%
LoseDBD / S&P
5.44% / 15.00%
LoseDBD / S&P
-991.18% / 50.40%
2026-Q11/3 WinDBD / S&P
11.12% / -4.33%
LoseDBD / S&P
4.32% / 11.30%
LoseDBD / S&P
-1181.48% / 27.70%
2025-Q41/3 WinDBD / S&P
19.04% / 2.65%
LoseDBD / S&P
1.46% / 9.00%
LoseDBD / S&P
-681.82% / 13.40%
2025-Q30/3 LoseDBD / S&P
2.94% / 8.12%
LoseDBD / S&P
DBD unavailable / 4.61%
LoseDBD / S&P
DBD unavailable / 13.45%
2025-Q21/3 WinDBD / S&P
26.72% / 10.94%
LoseDBD / S&P
DBD unavailable / 4.83%
LoseDBD / S&P
DBD unavailable / 10.63%
2025-Q11/3 WinDBD / S&P
1.58% / -4.27%
LoseDBD / S&P
DBD unavailable / 4.98%
LoseDBD / S&P
DBD unavailable / 10.57%
2024-Q40/3 LoseDBD / S&P
-3.63% / 2.41%
LoseDBD / S&P
DBD unavailable / 5.25%
LoseDBD / S&P
DBD unavailable / 6.15%
2024-Q31/3 WinDBD / S&P
16.06% / 5.89%
LoseDBD / S&P
DBD unavailable / 5.89%
LoseDBD / S&P
DBD unavailable / 6.11%
2024-Q21/3 WinDBD / S&P
11.73% / 4.28%
LoseDBD / S&P
DBD unavailable / 5.38%
LoseDBD / S&P
DBD unavailable / 5.12%
2024-Q11/3 WinDBD / S&P
18.96% / 10.56%
LoseDBD / S&P
DBD unavailable / 5.71%
LoseDBD / S&P
DBD unavailable / 5.59%
2023-Q41/3 WinDBD / S&P
52.85% / 11.69%
LoseDBD / S&P
DBD unavailable / 6.81%
LoseDBD / S&P
DBD unavailable / 7.78%
2023-Q30/3 LoseDBD / S&P
DBD unavailable / -3.27%
LoseDBD / S&P
DBD unavailable / 7.52%
LoseDBD / S&P
DBD unavailable / -5.03%
2023-Q20/3 LoseDBD / S&P
DBD unavailable / 8.74%
LoseDBD / S&P
-3.78% / 9.50%
LoseDBD / S&P
DBD unavailable / -8.57%
2023-Q10/3 LoseDBD / S&P
DBD unavailable / 7.50%
LoseDBD / S&P
-7.97% / 10.77%
LoseDBD / S&P
DBD unavailable / -15.69%
2022-Q40/3 LoseDBD / S&P
DBD unavailable / 7.56%
LoseDBD / S&P
-11.38% / 11.88%
LoseDBD / S&P
DBD unavailable / -17.99%
2022-Q30/3 LoseDBD / S&P
DBD unavailable / -4.88%
LoseDBD / S&P
-10.12% / 13.47%
LoseDBD / S&P
DBD unavailable / -1.41%
2022-Q20/3 LoseDBD / S&P
DBD unavailable / -16.10%
LoseDBD / S&P
-7.25% / 13.71%
LoseDBD / S&P
DBD unavailable / 11.04%
2022-Q10/3 LoseDBD / S&P
DBD unavailable / -4.60%
LoseDBD / S&P
-3.67% / 15.97%
LoseDBD / S&P
DBD unavailable / 42.23%
2021-Q40/3 LoseDBD / S&P
DBD unavailable / 11.03%
LoseDBD / S&P
0.07% / 15.00%
LoseDBD / S&P
DBD unavailable / 96.40%
2021-Q30/3 LoseDBD / S&P
DBD unavailable / 0.58%
LoseDBD / S&P
0.09% / 10.77%
LoseDBD / S&P
DBD unavailable / 69.42%
2021-Q20/3 LoseDBD / S&P
DBD unavailable / 8.55%
LoseDBD / S&P
-1.07% / 6.58%
LoseDBD / S&P
DBD unavailable / 51.81%
2021-Q10/3 LoseDBD / S&P
DBD unavailable / 6.17%
LoseDBD / S&P
-8.29% / -1.06%
LoseDBD / S&P
DBD unavailable / 7.39%
2020-Q40/3 LoseDBD / S&P
DBD unavailable / 12.15%
LoseDBD / S&P
-11.49% / -3.72%
LoseDBD / S&P
DBD unavailable / -33.42%
2020-Q30/3 LoseDBD / S&P
DBD unavailable / 8.93%
LoseDBD / S&P
-13.17% / -2.04%
LoseDBD / S&P
DBD unavailable / -27.10%
2020-Q20/3 LoseDBD / S&P
DBD unavailable / 20.54%
LoseDBD / S&P
-12.11% / -0.46%
LoseDBD / S&P
DBD unavailable / -27.11%
2020-Q10/3 LoseDBD / S&P
DBD unavailable / -19.60%
LoseDBD / S&P
-5.53% / 3.47%
LoseDBD / S&P
DBD unavailable / -14.75%
2019-Q40/3 LoseDBD / S&P
DBD unavailable / 9.07%
LoseDBD / S&P
-3.71% / 5.36%
LoseDBD / S&P
DBD unavailable / 2.99%
2019-Q30/3 LoseDBD / S&P
DBD unavailable / 1.70%
LoseDBD / S&P
0.18% / 5.02%
LoseDBD / S&P
-39.30% / 0.21%
2019-Q21/3 LoseDBD / S&P
DBD unavailable / 4.30%
LoseDBD / S&P
0.98% / 6.64%
WinDBD / S&P
51.16% / 8.65%
2019-Q11/3 LoseDBD / S&P
DBD unavailable / 13.65%
LoseDBD / S&P
-0.62% / 8.12%
WinDBD / S&P
144.08% / 14.29%
2018-Q41/3 LoseDBD / S&P
DBD unavailable / -13.52%
LoseDBD / S&P
-0.67% / 9.05%
WinDBD / S&P
134.48% / 18.23%
2018-Q31/3 LoseDBD / S&P
DBD unavailable / 7.71%
LoseDBD / S&P
-1.39% / 10.21%
WinDBD / S&P
151.88% / 19.06%
2018-Q21/3 LoseDBD / S&P
DBD unavailable / 3.43%
LoseDBD / S&P
1.77% / 9.03%
WinDBD / S&P
21.59% / 14.46%
2018-Q11/3 LoseDBD / S&P
DBD unavailable / -0.76%
WinDBD / S&P
16.91% / 7.68%
LoseDBD / S&P
-11.05% / 12.46%
2017-Q42/3 LoseDBD / S&P
DBD unavailable / 6.64%
WinDBD / S&P
38.99% / 7.03%
WinDBD / S&P
593.48% / 13.82%
2017-Q31/3 LoseDBD / S&P
DBD unavailable / 4.48%
WinDBD / S&P
71.54% / 5.68%
LoseDBD / S&P
-327.13% / 17.57%
2017-Q21/3 LoseDBD / S&P
DBD unavailable / 3.09%
WinDBD / S&P
94.94% / 4.83%
LoseDBD / S&P
-227.12% / 17.74%
2017-Q11/3 LoseDBD / S&P
DBD unavailable / 6.07%
WinDBD / S&P
66.07% / 3.67%
LoseDBD / S&P
-202.15% / 13.32%
2016-Q41/3 LoseDBD / S&P
DBD unavailable / 3.82%
WinDBD / S&P
37.08% / 2.09%
LoseDBD / S&P
-141.07% / 7.05%
2016-Q32/3 LoseDBD / S&P
DBD unavailable / 3.85%
WinDBD / S&P
13.99% / 0.20%
WinDBD / S&P
18.35% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricDBD total returnS&P 500 Total Return Index
Total return10.75%20.78%
Annualized return10.75%20.78%

5Y · 2023-08-14 to 2026-08-27

MetricDBD total returnS&P 500 Total Return Index
Total return229.02%83.14%
Annualized return26.90%12.86%

10Y · 2023-08-14 to 2026-08-27

MetricDBD total returnS&P 500 Total Return Index
Total return229.02%319.30%
Annualized return12.65%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
NCR Voyix Corp (VYX)United States$0.979B14.79
NCR Atleos Corp (NATL)United States$3.394B16.18
PAR TECHNOLOGY CORP (PAR)United States$0.577B-10.00